ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTBiocompatible and Bioactive Surface Modifications for Prolonged In Vivo EfficacySteven R. Meyers and Mark W. Grinstaff*View Author Information Departments of Biomedical Engineering and Chemistry, Boston University, Boston, Massachusetts 02215, United States*E-mail: [email protected]Cite this: Chem. Rev. 2012, 112, 3, 1615–1632Publication Date (Web):October 18, 2011Publication History Received30 March 2011Published online18 October 2011Published inissue 14 March 2012https://pubs.acs.org/doi/10.1021/cr2000916https://doi.org/10.1021/cr2000916review-articleACS PublicationsCopyright © 2011 American Chemical SocietyRequest reuse permissionsArticle Views5647Altmetric-Citations218LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Alcohols,Cells,Coating materials,Implants,Peptides and proteins Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Meyers et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: